Valeant Chops 2850 Workers After Recent Bausch and Lomb Deal
July 31st, 2013 // 11:43 am @ jmpickett
Latest FDA and cGMP Compliance News
Valeant Pharmaceuticals has started to digest its $9 billion of Bausch and Lomb, about 2850 jobs are going to be chopped from a workforce of about 20,000 workers, as the firm is trying to save about $750 million over the next 18 months. This information was released to employees in a memo, which was filed with the SEC.
Valeant expects to cut up to 15% of its total head count, which includes about 7400 Valeant employees and about 12,000 Bausch and Lomb employees. The corporate headquarters are going to stay in Quebec, and the US HQ is going to stay in New Jersey, but other facilities may be closed or moved.
